FDA-approved drugs promise new hair growth
Advertisement
New York: There is good news for people suffering from hair loss. In experiments with mouse and human hair follicles, researchers have found that certain existing drugs promote rapid and robust hair growth when directly applied to the skin.
The study raises the possibility that drugs that inhibit the Janus kinase (JAK) family of enzymes could be used to restore hair growth in multiple forms of hair loss such as that induced by male pattern baldness.
"What we have found is promising, though we have not yet shown it is effective for male pattern baldness," said one of the researchers Angela Christiano from Columbia University Medical Centre in the US.
Two JAK inhibitors have been approved by the US Food and Drug Administration (FDA). One is approved for treatment of blood diseases (ruxolitinib) and the other for rheumatoid arthritis (tofacitinib), the study pointed out.
The study raises the possibility that drugs that inhibit the Janus kinase (JAK) family of enzymes could be used to restore hair growth in multiple forms of hair loss such as that induced by male pattern baldness.
"What we have found is promising, though we have not yet shown it is effective for male pattern baldness," said one of the researchers Angela Christiano from Columbia University Medical Centre in the US.
Two JAK inhibitors have been approved by the US Food and Drug Administration (FDA). One is approved for treatment of blood diseases (ruxolitinib) and the other for rheumatoid arthritis (tofacitinib), the study pointed out.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.